Literature DB >> 15181578

Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy.

Peter K C Goon1, Alix Biancardi, Noam Fast, Tadahiko Igakura, Emmanuel Hanon, Angelina J Mosley, Becca Asquith, Keith G Gould, Sara Marshall, Graham P Taylor, Charles R M Bangham.   

Abstract

Human T cell lymphotropic virus type 1 (HTLV-1) causes HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). We used interferon- gamma enzyme-linked immunospot assays with overlapping peptides spanning the entire HTLV-1 proteome to test whether the HTLV-1-specific CD8(+) T cells differed significantly in frequency or immunodominance hierarchy between patients with HAM/TSP and asymptomatic carriers and whether the frequency correlated with provirus load. Tax was the immunodominant target antigen. There was no significant qualitative or quantitative difference in the HTLV-1-specific CD8(+) T cell response between the 2 groups. Virus-specific CD8(+) T cell frequency alone does not indicate the effectiveness of the cytotoxic T lymphocyte response in controlling provirus load at equilibrium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15181578     DOI: 10.1086/420832

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  34 in total

Review 1.  Vaccines to prevent infections by oncoviruses.

Authors:  John T Schiller; Douglas R Lowy
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

2.  Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease.

Authors:  Sharrón L Manuel; Todd D Schell; Edward Acheampong; Saifur Rahman; Zafar K Khan; Pooja Jain
Journal:  J Leukoc Biol       Date:  2009-08-05       Impact factor: 4.962

3.  Cellular Immune Responses against Simian T-Lymphotropic Virus Type 1 Target Tax in Infected Baboons.

Authors:  Iris Castro; Teresa M Giret; Diogo M Magnani; Helen S Maxwell; Oliver Umland; Jessica K Perry; Jerilyn K Pecotte; Kathleen M Brasky; Glen N Barber; Ronald C Desrosiers; David I Watkins
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

Review 4.  Human T-cell lymphotropic virus type 1 and its oncogenesis.

Authors:  Lan-Lan Zhang; Jing-Yun Wei; Long Wang; Shi-le Huang; Ji-Long Chen
Journal:  Acta Pharmacol Sin       Date:  2017-04-10       Impact factor: 6.150

5.  Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection.

Authors:  Rashade A H Haynes; Andrew J Phipps; Brenda Yamamoto; Patrick Green; Michael D Lairmore
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

6.  Immunogenetics and the Pathological Mechanisms of Human T-Cell Leukemia VirusType 1- (HTLV-1-)Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).

Authors:  Mineki Saito
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-10

7.  HLA class I binding of HBZ determines outcome in HTLV-1 infection.

Authors:  Aidan Macnamara; Aileen Rowan; Silva Hilburn; Ulrich Kadolsky; Hiroshi Fujiwara; Koichiro Suemori; Masaki Yasukawa; Graham Taylor; Charles R M Bangham; Becca Asquith
Journal:  PLoS Pathog       Date:  2010-09-23       Impact factor: 6.823

8.  In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection.

Authors:  Becca Asquith; Yan Zhang; Angelina J Mosley; Catherine M de Lara; Diana L Wallace; Andrew Worth; Lambrini Kaftantzi; Kiran Meekings; George E Griffin; Yuetsu Tanaka; David F Tough; Peter C Beverley; Graham P Taylor; Derek C Macallan; Charles R M Bangham
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-01       Impact factor: 11.205

9.  IFN-gamma production in response to Tax 161-233, and frequency of CD4+ Foxp3+ and Lin HLA-DRhigh CD123+ cells, discriminate HAM/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population.

Authors:  Ivan Best; Giovanni López; Kristien Verdonck; Elsa González; Martín Tipismana; Eduardo Gotuzzo; Guido Vanham; Daniel Clark
Journal:  Immunology       Date:  2009-02-17       Impact factor: 7.397

10.  The genomic landscape of adult T cell leukemia/lymphoma.

Authors:  Carmen Vicente; Jan Cools
Journal:  Nat Genet       Date:  2015-11       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.